Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT03244072
PHASE2/PHASE3
Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
Sponsor: Jason Ahee, M.D.
View on ClinicalTrials.gov
Summary
Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis
Official title: Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60000
Start Date
2026-06-01
Completion Date
2031-10
Last Updated
2025-09-25
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Moxifloxacin
Intracameral injection
DRUG
Placebo
intracameral injection
Locations (1)
Zion Eye Institute
St. George, Utah, United States